Completed
Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT00428948
- Conditions
- Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, +12 more
- Locations
-
- Coastal Clinical Research Mobile, Alabama, United States
- University of South Alabama Mobile, Alabama, United States
- Apex Research of Riverside Riverside, California, United States
- Stanford University Medical Center Stanford, California, United States